Valsartan salts

Title: Valsartan salts

Related Patent Categories: Drug, Bio-affecting And Body Treating Compositions, Designated Organic Active Ingredient Containing (doai), Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai, Five-membered Hetero Ring Containing At Least One Nitrogen Ring Atom (e.g., 1,2,3-triazoles, Etc.), Tetrazoles (including Hydrogenated)

Brief Patent Description - Full Patent Description - Patent Claims

The Patent Description & Claims data below is from USPTO Patent Application 20070149587, Valsartan salts.

1. A calcium salt of valsartan.

2. A salt according to claim 1 in crystalline, partially crystalline or amorphous form.

3. The tetrahydrate of the calcium salt of valsartan according to claim 1.

4. The tetrahydrate according to claim 3, characterised by (i) an X-ray powder pattern taken with a Guinier camera comprising the following interlattice plane intervals: d in [.ANG.]: 16.1.+-.0.3, 9.9.+-.0.2, 9.4.+-.0.2, 7.03.+-.0.1, 6.50.+-.0.1, 5.87.+-.0.05, 5.74.+-.0.05, 4.95.+-.0.05, 4.73.+-.0.05, 4.33.+-.0.05, 4.15.+-.0.05, 4.12.+-.0.05, 3.95.+-.0.05; or (ii) an ATR-IR spectrum having the following absorption bands expressed in reciprocal wave numbers (cm.sup.-1): 1621 (st); 1578 (m); 1458 (m); 1441 (m); 1417 (m); 1364 (m); 1012 (m); 758 (m); 738 (m); 696 (m); 666 (m).

5. A salt according to claim 1 in the form of a solvate.

6. A salt according to claim 1 in the form of a hydrate.

7. A salt according to claim 1 in a form selected from the group consisting of (i) a crystalline form; (ii) a partly crystalline form; (iii) an amorphous form; and (iv) a polymorphous form.

8. A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable excipient or additive.

9. A pharmaceutical composition according to claim 8, containing a salt according to claim 1 in combination with at least one composition selected from the group consisting of a: (i) HMG-Co-A reductase inhibitor or a pharmaceutically acceptable salt thereof, (ii) angiotensin converting enzyme (ACE) Inhibitor or a pharmaceutically acceptable salt thereof, (iii) calcium channel blocker or a pharmaceutically acceptable salt thereof, (iv) aldosterone synthase inhibitor or a pharmaceutically acceptable salt thereof, (v) aldosterone antagonist or a pharmaceutically acceptable salt thereof, (vi) dual angiotensin converting enzyme/neutral endopeptidase (ACE/NEP) inhibitor or a pharmaceutically acceptable salt thereof, (vii) endothelin antagonist or a pharmaceutically acceptable salt thereof, (viii) renin inhibitor or a pharmaceutically acceptable salt thereof, and (ix) diuretic or a pharmaceutically acceptable salt thereof.

10. A method for the treatment of diseases and conditions which can be inhibited by blocking the AT.sub.1 receptor comprising administering a therapeutically effective amount of the compound of claim 1 to a patient on need thereof.

Brief Patent Description - Full Patent Description - Patent Claims

Click on the above for other options relating to this Valsartan salts patent application.
###

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.
Start now! - Receive info on patent apps like Valsartan salts or other areas of interest.
###

Previous Patent Application:
New crystalline and stable form of andolast
Next Patent Application:
6-(2,3,6-trifluorophenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
Industry Class:
Drug, bio-affecting and body treating compositions

###

Design/code © 2009 FreshContext LLC/Freshpatents.com. Website Terms and Conditions - Also read: About this Page
Patent data source: patents published by the United States Patent and Trademark Office (USPTO)
Information published here is for research/educational purposes only (and in conjunction with our Keyword Monitor) and is not meant to be used in place of the full USPTO patent document/images or a comprehensive patent archive search. Complete official applications are on file at the USPTO and often contain additional data/images (Freshpatents is currently text-only). FreshPatents.com is not affiliated with or endorsed by the USPTO or firms/individuals or products/designs/ideas related to listed patents.

FreshPatents.com Support
Thank you for viewing the Valsartan salts patent info.
IP-related news and info

Results in 1.60314 seconds

Other interesting Feshpatents.com categories:
Medical: Surgery , Surgery(2) , Surgery(3) , Drug , Drug(2) , Prosthesis , Dentistry 174

* Protect your Inventions
* US Patent Office filing

Provisional Patent
Utility Patent

PATENT INFO